Cargando…
Enhancement of a T(H)1 Immune Response in Amphotericin B-Treated Mucocutaneous Leishmaniasis
In an attempt to investigate the effects of treatment of human leishmaniasis, the cytokines produced by peripheral blood mononuclear cells (PBMCs) of patients with cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL) under treatment with amphotericin B were determined during the active...
Autores principales: | Cuna, Washington R., Velasquez, Rianed, Riva, Janeth, Guachalla, Ingrid, Rodríguez, Celeste |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906706/ https://www.ncbi.nlm.nih.gov/pubmed/17641726 http://dx.doi.org/10.1155/2007/96410 |
Ejemplares similares
-
Treatment Strategies for Mucocutaneous Leishmaniasis
por: Palumbo, Emilio
Publicado: (2010) -
Ocular Leishmaniasis Treated by Intralesional Amphotericin B
por: Nikandish, Malihe, et al.
Publicado: (2016) -
Cheilitis: An unusual presentation of Mucocutaneous Leishmaniasis
por: Sujanitha, Vathulan, et al.
Publicado: (2018) -
Epidemiology of cutaneous and mucocutaneous leishmaniasis in Nicaragua
por: Hernández-Bojorge, Santiago E., et al.
Publicado: (2020) -
Mucocutaneous Leishmaniasis in a Pregnant Immigrant
por: Briggs, Neima, et al.
Publicado: (2022)